LUPUS ERYTHEMATOSUS
Clinical trials for LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot cell therapy tested for devastating autoimmune diseases
Disease control OngoingThis is an early safety study testing a single dose of an experimental cell therapy called SC291. It is for adults with severe forms of lupus or a blood vessel disease called ANCA-associated vasculitis that have not improved with at least two prior treatments. The goal is to see …
Matched conditions: LUPUS ERYTHEMATOSUS
Phase: PHASE1 • Sponsor: Sana Biotechnology • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
CRISPR cell therapy trial for tough lupus cases withdrawn before starting
Disease control TerminatedThis early-stage study aimed to test the safety and initial effects of a single infusion of CB-010, a new type of cell therapy modified with CRISPR gene-editing, in adults with severe lupus that hasn't responded to standard treatments. The trial was designed to last about two yea…
Matched conditions: LUPUS ERYTHEMATOSUS
Phase: PHASE1 • Sponsor: Caribou Biosciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC